These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 1300870
1. Anti-neutrophil cytoplasm antibodies in giant cell arteritis and polymyalgia rheumatica. Meyer O, De Bandt M, Haim T, Kahn MF. Ann Med Interne (Paris); 1992; 143(7):476. PubMed ID: 1300870 [No Abstract] [Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibodies in giant cell arteritis and polymyalgia rheumatica. Cats HA, Tervaert JW, van Wijk R, Limburg PC, Kallenberg CG. Adv Exp Med Biol; 1993 Feb; 336():363-6. PubMed ID: 8296636 [Abstract] [Full Text] [Related]
7. HLA-DR locus antigens in polymyalgia rheumatica and giant cell arteritis. Calamia KT, Moore SB, Elveback LR, Hunder GG. J Rheumatol; 1981 Feb; 8(6):993-6. PubMed ID: 6948960 [Abstract] [Full Text] [Related]
8. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Dasgupta B, Duke O, Kyle V, Macfarlane DG, Hazleman BL, Panayi GS. Ann Rheum Dis; 1987 Oct; 46(10):746-9. PubMed ID: 2446569 [Abstract] [Full Text] [Related]
10. HLA-DR antigens in polymyalgia rheumatica and giant cell arteritis. Gouet D, Alcalay D, Azais I, Alcalay M, Becq-Giraudon B, Sudre Y, Bontoux D. J Rheumatol; 1985 Jun; 12(3):627-8. PubMed ID: 3862847 [No Abstract] [Full Text] [Related]
11. Lack of consistent peripheral blood lymphocyte transformation responses in polymyalgia rheumatica and giant cell arteritis. Jones JG, Park JR, Hazelman BL, Ward M, Bulgen DY. J Rheumatol; 1980 Jun; 7(6):891-4. PubMed ID: 7205827 [Abstract] [Full Text] [Related]
12. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Manna R, Latteri M, Cristiano G, Todaro L, Scuderi F, Gasbarrini G. Br J Rheumatol; 1998 Feb; 37(2):208-10. PubMed ID: 9569078 [Abstract] [Full Text] [Related]
13. Hypothyroidism in polymyalgia rheumatica and giant cell arteritis. Wiseman P, Stewart K, Rai GS. BMJ; 1989 Mar 11; 298(6674):647-8. PubMed ID: 2496792 [No Abstract] [Full Text] [Related]
14. [Prevalence of antiphospholipid antibodies in Horton's disease and in polymyalgia rheumatica]. Hulin C, Hachulla E, Michon-Pasturel U, Hatron PY, Masy E, Gillot JM, Caron C, Arvieux J, Flipo RM, Devulder B. Rev Med Interne; 1999 Aug 11; 20(8):659-63. PubMed ID: 10480168 [Abstract] [Full Text] [Related]
16. In vitro lymphocyte cytotoxicity to cultured human arterial smooth muscle cells in patients with giant cell arteritis and polymyalgia rheumatica. Park JR, Jones JG, Hazleman BL. J Rheumatol; 1981 Aug 11; 8(1):125-8. PubMed ID: 7218240 [Abstract] [Full Text] [Related]
17. Immunoglobulin allotypes in patients with giant cell arteritis and polymyalgia rheumatica. Pandey JP, Hunder GG, Fudenberg HH, Loadholt CB. J Immunogenet; 1982 Jun 11; 9(3):165-7. PubMed ID: 7108250 [No Abstract] [Full Text] [Related]
18. [Polymyalgia rheumatica and temporal arteritis: one or two diseases?]. Bograd H, Garfinkel D, Weinberger A, Pinkhas J. Harefuah; 1982 Jun 11; 103(12):371-3. PubMed ID: 7183495 [No Abstract] [Full Text] [Related]
19. Antibodies to intermediate filaments in polymyalgia rheumatica/giant cell arteritis: do they reflect the underlying disease activity rather than the acute phase response? Monteagudo I, Corrigall V, Panayi GS, Pountain G, Hazleman BL. Ann Rheum Dis; 1994 Feb 11; 53(2):150. PubMed ID: 8129464 [No Abstract] [Full Text] [Related]